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Summary objective To compare the performance of the Paracheck rapid diagnostic test (RDT) with
microscopy for diagnosing malaria in hospitalised children.
methods Children aged between 2 months and 13 years with fever were enrolled in the study over
1 year. A standard clinical history and examination were recorded and blood drawn for culture,
complete blood count, Paracheck RDT and double-read blood slide.
results Of 3639 children enrolled, 2195 (60.3%) were slide positive. The sensitivity and specificity
of Paracheck were 97.5% (95% CI 96.9–98.0) and 65.3% (95% CI 63.8–66.9), respectively. There was
an inverse relationship between age-specific prevalence of parasitaemia and Paracheck specificity. In
logistic regression model, false-positive Paracheck results were significantly associated with pre-
admission use of antimalarial drug (OR 1.44, 95% CI 1.16–1.78), absence of current fever (OR 0.64,
95% CI 0.52–0.79) and non-typhi Salmonella bacteraemia (OR 3.89. 95% CI 2.27–6.63). In spite of
high sensitivity, 56 ⁄2195 (2.6%) of true infections were Paracheck negative and 8 ⁄56 (14.3%) were in
patients with >50 000 parasites ⁄ll.
conclusions Paracheck had poor specificity in diagnosing malaria in severely ill children; this was
likely to be due to HRP2 persistence following recent parasite clearance. The combination of positive
Paracheck and negative blood slide results identified a group of children at high risk of non-typhi
Salmonella infection. While Paracheck was highly sensitive, some high-density infections were missed.
For children with severe febrile illness, at least two reliable negative parasitological test results should be
available to justify withholding antimalarial treatment; the optimal choice of these has yet to be
identified.
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Introduction
The use of rapid immunochromatographic tests for malaria
(RDTs) in primary care facilities has been studied over a
number of years, and these tests are now being rolled out
on a large scale in Africa as a means to restrict antimalarial
drug use to parasitologically confirmed cases, a policy now
supported by WHO (WHO 2010). However, the WHO
criteria for malaria diagnosis apply irrespective of severity,
and it is therefore surprising that as far as we are aware,
only one small study has so far been published on the use of
RDTs in patients admitted to hospital (Birku et al. 1999).
The wider use of RDTs in patients hospitalised with
severe febrile illness seems inevitable given the increasing
availability of RDTs. Given current evidence of the low
accuracy of routinely read slide results, this may represent
an improvement over current practice (Reyburn et al.
2004; Zurovac et al. 2006). However, the performance of
HRP2-based RDTs may differ when used for severely ill
children compared to use in non-severe illness. First,
specificity may be reduced by the persistence of HRP2 for
up to 5 weeks following clearance of parasites and this
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may be a particular concern in patients who are frequently
infected or who have recently taken antimalarial drugs,
both of which may be more likely in hospitalised children
in malaria-endemic areas (Wongsrichanalai et al. 1999;
Swarthout et al. 2007). Secondly, it has been suggested
that test sensitivity may paradoxically decline at very high
parasite densities (more common in severe than non-severe
malaria) because of flooding of RDT capture sites (Rey-
burn et al. 2007). Thirdly, antibodies to HRP2 that are
acquired with increasing exposure to malaria might result
in age-dependent test performance (Biswas et al. 2005).
And finally, the interpretation of a combination of a
positive RDT result and negative blood slide may indicate
‘recent malaria’ and this has been associated with certain
bacterial infections in severely ill children that may provide
added diagnostic value if both RDT and blood slide results
are available (Brent et al. 2006; Nadjm et al. 2010).
In this study, we compared results of a commonly used
HRP2-based RDT (Paracheck) with those from double-
read research slides in guiding the care of children enrolled
in a 1-year study of children admitted to a district hospital
for febrile illness in an area of intense malaria transmission.
We compare the technical performance of Paracheck with
research-quality blood slide results and suggest how HRP-
2-based RDT results might contribute to clinical care in
African district hospitals.
Methods
Study site and data collection
The study was conducted in a district hospital in north-
eastern Tanzania serving a predominantly rural population
with childhood mortality that is typical for Tanzania (165
deaths ⁄1000 person years under the age of 5 years). The
area is highly endemic for Plasmodium falciparum
(P. falciparum) malaria.
Details of the study have been published elsewhere
(Nadjm et al. 2010). Briefly, over the course of 1 year, all
daytime paediatric admissions were screened for inclusion
and were eligible if aged 2 months to 13 years with axillary
temperature ‡37.5 C or a history of fever within the
previous 48 h. Children with chronic illness except HIV or
admitted with trauma or a surgical condition were
excluded.
After consenting procedures, a standard clinical history
and examination based on IMCI guidelines were recorded
by a study clinician (WHO 2000a). Pulse oximetry was
used on a finger or toe and height and weight were
measured. Lumbar puncture was undertaken on suspicion
of meningitis according to WHO criteria. Venous blood
was drawn for point of care (POC) tests of haemoglobin
concentration, blood glucose (Hemocue, Anglholm,
Sweden), blood lactate (Lactate-Pro; Arkray Inc, Kyoto,
Japan), HRP-2-based RDT for P. falciparum (Paracheck;
Orchid Biomedical, Mumbai, India) and HIV antibody
tests (Capillus HIV-1, HIV-2 Test; Trinity Biotech, Ireland
and Determine HIV-1 ⁄2 Test; Abbott Laboratories, IL,
USA). Blood was sent to the laboratory for full blood count
(Act ⁄Dif; Beckman-Coulter) and aerobic blood culture
(BactAlert; Biomerieux, France) with identification of
organisms by standard means. Blood slides were stained
with Giemsa and independently double-read with discor-
dant results resolved by a third reader. Paracheck tests
were stored in a ventilated room out of direct sunlight with
temperature documented not to exceed 40 C as recom-
mended by the manufacturer.
Data management and analysis
Data were scanned using Teleforms (Verity software Inc.)
into MS-Access (Microsoft Corp, Redmond, VA, USA) and
analysed using Stata-10 (Stata Corp, College Rd, TX,
USA). Final blood slide results are considered as the
‘reference standard’ result in making comparisons with
Paracheck results throughout the paper.
Statistical tests used chi-squared for comparison of
proportions and t-test (for parametric variable) or rank-sum
(for non-parametric variable) for comparison of normally
or non-normally distributed data, respectively. The logistic
model was constructed with ‘positive RDT and negative
blood slide’ as the dependent variable and factors in
Table 3 as independent variables. All of the initially chosen
independent variables were retained in the final model.
Ethics
The study was approved by the Ethics Committees of the
National Institute for Medical Research, Tanzania
(NIMR ⁄HQ ⁄R.8a ⁄Vol.IX ⁄392), and the London School of
Hygiene and Tropical Medicine, UK (LSHTM Ethics
# 2087). Witten informed consent to participate was
obtained from the parent or guardian of each child in the
study.
Results
After exclusions for missing data, 3639 children were
included in the analysis, all of whom had a blood slide and
Paracheck result. Overall, 2139 (58.8%) were both
P. falciparum slide positive and Paracheck positive, and
943 (25.9%) were negative to both tests. Of the 557
discordant results, 501 ⁄557 (90%) were Paracheck posi-
tive but slide negative and 56 ⁄557 (10%) were Paracheck
negative and slide positive. Using the blood slide result as
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the reference standard, there was an inverse relationship
between age-specific prevalence of parasitaemia and the
specificity of Paracheck (Table 1, Figure 1).
The sensitivity of Paracheck was above 95% in detecting
P. falciparum infections with >2000 parasites ⁄ll with no
consistent trend with increasing density above this level.
The sensitivity of Paracheck was lower in detecting
infections with <2000 parasites ⁄ll and especially infections
with <200 parasites ⁄ll compared to infections with
>2000 ⁄ll (Table 2). However, low-density infections were
relatively uncommon; only 20 ⁄2139 (0.9%) and 240 ⁄2,
139 (11.2%) of positive blood slide results were at
densities of <200 and <2000 parasites ⁄ll, respectively.
More than half of all false-negative Paracheck results
(30 ⁄56, 53.6%) were in children with a parasite density of
>2000 parasites ⁄ll and 8 ⁄56 (14.3%) were in children
with parasite densities greater than 50 000 ⁄ll.
An invasive bacterial infection was isolated in 341 ⁄3639
(9.4%) children in the study and these were more common
in slide-negative (241 ⁄1444, 16.7%) compared to slide-
positive children (100 ⁄2195, 4.6%, P < 0.001). Similarly,
bacterial infection was more common in RDT-negatives
than in RDT-positives; 194 ⁄2640 (7.4%) of RDT-positive
and 147 ⁄999 (14.7%) of RDT-negative children had
invasive bacterial disease (P < 0.001). However, of the 501
children who were slide negative but Paracheck positive,
98 (19.6%) had invasive bacterial disease and 67 (69.1%)
of these were caused by non-typhi Salmonella (NTS)
infections (Table 3).
Overall, 597 ⁄1850 (32.3%) of children with a true-
positive Paracheck result were reported to have taken an
antimalarial drug in the 2 days prior to admission com-
pared to 188 ⁄443 (42.4%) of children with a false-positive
Paracheck result (P < 0.001). Factors judged likely to be
associated with false-positive Paracheck results were
assessed in the logistic regression model in Table 4.
Discussion
The main finding of the study was the low specificity of
Paracheck compared to reference blood slides; the overall
Table 1 Age-specific sensitivity, specificity and predictive values of Paracheck compared to blood slide results in 3639 children in the study
Prevalence of
slide positive
Sensitivity %
(95% CI)
Specificity %
(95% CI)
Positive predictive
value % (95% CI)
Negative predictive
value % (95% CI)
2–11 months 487 ⁄ 1054 (46.2%) 96.4 (95.3–97.5) 75.5 (72.3–78.1) 77.3 (74.8–79.8) 96.0 (94.9–97.2)
12–23 months 740 ⁄ 1139 (65.0%) 97.7 (96.8–98.6) 62.2 (59.3–65.0) 82.7 (80.5–84.9) 93.6 (92.2–95.0)
24–59 months 811 ⁄ 1134 (71.5%) 98.2 (97.4–99.0) 48.9 (46.0–51.8) 82.8 (80.6–85.0) 91.3 (89.7–93.0)
60+ months 157 ⁄ 312 (50.3%) 96.2 (94.1–98.3) 70.3 (65.3–75.4) 76.7 (72.0–81.3) 94.8 (92.3–97.3)
Total 2195 ⁄ 3639 (60.3%) 97.5 (96.9–98.0) 65.3 (63.8–66.9) 81.0 (79.8–82.3) 94.4 (93.7–95.1)
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Figure 1 Age-specific sensitivity and specificity of rapid diagnostic
test results by prevalence of a positive blood slide of children in the
study.
Table 2 Sensitivity of Paracheck results by
parasite density of reference blood slide
results Parasite density ⁄ ll Prevalence
RDT
positive
RDT
negative
Sensitivity
(95% CI)
1–199 20 ⁄ 1464 (1.4%) 16 4 80.0 (78.0–82.1)
200–1999 220 ⁄ 1664 (13.2%) 198 22 90.0 (88.6–91.4)
2000–4999 165 ⁄ 1609 (10.3%) 159 6 96.4 (95.5–97.3)
5000–49 999 917 ⁄ 2361 (38.8%) 901 16 98.3 (97.7–98.8)
50 000–200 000 693 ⁄ 2137 (32.4%) 689 4 99.4 (99.1–99.7)
>200 000 180 ⁄ 1624 (11.1%) 176 4 97.8 (97.1–98.5)
RDT, rapid diagnostic test.
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figure was among the lowest recorded for Paracheck and in
children aged between 2 and 5 years, specificity dropped
below 50%. The proportion of Paracheck results that were
false-positives correlated closely with age-specific parasite
prevalence and recent antimalarial drug use but was not
independently associated with age.
The rate of false-positive Paracheck results is at least
partly a function of the time between parasite clearance
and disappearance of HRP2 from blood and this can last
for more than 5 weeks (Swarthout et al. 2007) and is likely
to be associated with recent antimalarial treatment. One
would expect this to be particularly common in children
who are admitted to a district hospital because this
constitutes the first referral level of care, and in our study,
we found that over one-third of all children in the study
and almost half of the children with a false-positive
Paracheck were reported to have taken an antimalarial
drug in the 2 days prior to admission. In addition, apparent
low specificity may be the result of Paracheck or other
RDTs exceeding blood slide results in sensitivity; studies by
both Bell et al. (2005) and Hopkins et al. (2008) have
found that a substantial proportion of results that were
negative to expert slide reading but positive to Paracheck
were positive when tested by polymerase chain reaction
(PCR). Without recourse to PCR, we are unable to
replicate this result but it seems likely that at least some of
the apparent low specificity of Paracheck that we observed
was the result of Paracheck detecting submicroscopic
parasitaemia.
The influence of antibodies to HRP2 on the accuracy of
RDTs is not clear. On the assumption that HRP antibodies
accelerate the disappearance of reactive HRP2, one would
expect RDT sensitivity and specificity to increase with
increasing exposure, for which age is a reasonable proxy in
a stable population such as that in our study area. This is
supported by the findings of (Fryauff et al. 1997) who
found a marked difference in sensitivity over and under the
age of 10 years among residents of a malaria-endemic area
of Irian Jaya, although in our study population, with a
much narrower age range, we did not observe age-specific
trends in sensitivity. Biswas et al. (2005) studied HRP2
levels and antibody titres to HRP2 in 45 subjects in a low-
transmission area for up to 6 weeks following infection
with P. falciparum and found that HRP2 antigen remained
elevated for at least 7 days post-treatment, despite the
development of HRP2-specific immune responses. Our
findings were thus consistent with the conclusions of
Biswas et al., that antibody levels to HRP2 are unlikely to
exert an important effect on test results in children with
severe febrile illness.
The relatively low specificity of Paracheck in our study
suggests that its use in a hospital setting will result in
significant overuse of antimalarial drugs with the possible
neglect of alternative diagnoses. Brent et al. (2006) previ-
ously described the strong association between a false-
positive RDT result and blood stream bacterial infections
caused by NTS and other Gram-negative organisms and
thus the combination of a negative blood slide result and
Table 4 Factors associated with the combination of a negative blood slide and positive Paracheck result
N (prevalence, %)
Unadjusted OR
(95% CI) P
Adjusted OR
(95% CI) P
Age 12–23 months 1073 (29.5) 1.00 (0.78–1.28) 0.96 1.06 (0.81–1.39) 0.430
Age 24–59 months 2254 (61.9) 1.12 (0.90–1.42) 0.36 1.22 (0.93–1.59) 0.160
Age 60+ months 312 (8.6) 1.14 (0.79–1.63) 0.48 1.35 (0.92–2.00) 0.130
Days ill, OR per day 1.10 (1.01–1.04) 0.002 1.01 (1.00–1.03) 0.113
Antimalarial in last 2 days 1102 (34.8) 1.46 (1.19–1.80) <0.001 1.44 (1.16–1.78) 0.001
Non-typhi Salmonella 169 (4.4) 5.05 (3.63–7.03) <0.001 3.82 (2.25–6.50) <0.001
Any invasive bacterial disease 341 (9.4) 2.90 (2.24–3.74) <0.001 1.52 (0.99–2.33) 0.054
Fever >37.5 C 2383 (65.6) 0.69 (0.57–0.84) <0.001 0.64 (0.52–0.79) <0.001
Table 3 Pathogenic bacteria isolated from
blood or CSF by category of Paracheck and
blood slide results
NTS Other organism Total
Slide negative and RDT negative 41 (4%) 102 (11%) 943
Slide negative and RDT positive 67 (13%) 31 (6%) 501
Slide positive, P.f. density <5000 ⁄ ll 23 (6%) 10 (2%) 405
Slide positive, P.f. density 5000–50 000 13 (1%) 18 (2%) 917
Slide positive, P.f. density 50 000+ 16 (2%) 20 (2%) 873
Total 160 (4%) 181 (5%) 3639
NTS, non-typhi Salmonella; RDT, rapid diagnostic test.
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positive Paracheck result should alert clinicians to the
possibility of these infections. Given the currently unsat-
isfactory clinical predictors of bacterial infection in chil-
dren admitted to hospital in resource-poor settings, this
could be a useful diagnostic aid, and a positive HRP2 RDT
result should not deter clinicians from providing pre-
sumptive treatment with antimicrobials, especially if the
blood slide is negative.
By contrast, Paracheck reached very high levels of
sensitivity and negative predictive values approached
100%, a finding consistent with other studies (Hopkins
et al. 2007; Laurent et al. 2010). As expected from results
of the recent WHO-sponsored evaluation of RDTs, sensi-
tivity dropped below 90% for the detection of low-density
infections but otherwise was consistently above the min-
imum level of recommended level of 95% (WHO 2000a,
2008). The relative importance of low-density infections
varies by their prevalence, and low-density infections are
more common in low-transmission areas and in asymp-
tomatic individuals; in a community survey in a low-
transmission area of the Solomon Islands, Harris et al.
(2010) found that almost half of all P. falciparum infec-
tions were with <100 parasites ⁄ll. This is in contrast to
hospitalised children in our study where <1% of infections
were in this category. Thus, in spite of the high sensitivity
of Paracheck in detecting infections above 2000 para-
sites ⁄ll, more than half of the false-negative Paracheck
results in our study were in children with >2000 para-
sites ⁄ll and almost one in six of the false-negative results
was in children with high-density (>50 000 parasites ⁄ll)
infections. False-negative RDT results at high density have
been described by at least two other studies although the
explanation is still not clear (Reyburn et al. 2007; Laurent
et al. 2010). The lack of association with increasing
parasite density in our study suggests that flooding of RDT
capture sites with excess antigen is an unlikely explanation.
Other explanations include mutations in the HRP locus
similar to those that have been found in South America
(Gamboa et al. 2010).
In practice, the small number of false-negative RDT
results that we observed suggests that it would be unwise to
withhold antimalarial treatment on the basis of a single
negative Paracheck result in a severely ill child. Ideally, at
least one other parasitological test result should be used
and results should ideally be available before starting
treatment. This could be a second RDT, preferably based
on the detection of alternative antigen to HRP2 such as
lactate dehydrogenase (LDH) or a rapidly read quality-
controlled blood slide; while the latter is clearly preferable,
the limitations on laboratory quality in Africa create
serious challenges. More research is needed on what is
sufficient evidence to justify withholding antimalarial
treatment in a severely ill child admitted to hospital in
malaria-endemic areas.
In conclusion, HRP-2 devices in hospitalised children in
high-transmission settings suffer from low specificity that is
largely dependent on the risk of recently cleared P. falci-
parum infection. Thus, in areas of intense transmission of
P. falciparum, patients may be overtreated with antima-
larial drugs and a positive HRP2 test result should not
discourage presumptive treatment with antimicrobial
drugs. The combination of a positive HRP2 test with a
negative blood slide result may suggest an increased risk of
invasive Gram-negative septicaemia. While the Paracheck
results in this study reached high levels of sensitivity, a
small number of high-density P. falciparum infections were
recorded as Paracheck-negative, suggesting that at least
one more quality-controlled parasitological test should be
used before withholding antimalarial treatment in patients
with suspected severe malaria. The choice of test or
combination of tests to guide treatment of children
admitted to hospital with suspected malaria has not so far
been defined.
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